Abiopharma

🔍 WEINSWIG MARK (Executive)

Company: Turtle Beach Corp (TBCH)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | shares_owned_after: 16,357.00
• Acquired 7,338 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,338.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Holds 80,262 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: H | shares_owned_after: 80,262.00 | Footnotes: F1, F3, F3

Footnotes:

• F1: The securities are Restricted stock units ("RSUs") representing a contingent right to receive one share of Turtle Beach Corporation common stock or, cash with a value equal to the fair market value of the underlying common stock or, a combination thereof.
• F2: One-quarter of these RSUs will vest on April 1, 2027, with the remainder of the RSUs vesting in equal annual installments until April 1, 2030.
• F3: One-quarter of these RSUs vested on February 3, 2026, with the remainder of the RSUs vesting in equal quarterly installments until February 3, 2029.